It appears JavaScript is disabled. In order for this website to function correctly you need to enable JavaScript in your browser.

Back to safety notices

PRAC meeting highlights 02 - 05 June 2025

06/06/2025

Medicines for human use Pharmacovigilance risk assessment committee (PRAC)

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

Highlights from the June 2025 meeting are now available on the EMA web site.